1. Yung AR, McGorry PD. The prodromal phase of first-episode psychosis: past and current conceptualizations. Schizophr Bull 1996;22:353-370.
3. Schultze-Lutter F, Michel C, Schmidt SJ, Schimmelmann BG, Maric NP, Salokangas RK, et al. EPA guidance on the early detection of clinical high risk states of psychoses. Eur Psychiatry 2015;30:405-416.
5. Comparelli A, Corigliano V, De Carolis A, Pucci D, Angelone M, Di Pietro S, et al. Anomalous self-experiences and their relationship with symptoms, neuro-cognition, and functioning in at-risk adolescents and young adults. Compr Psychiatry 2016;65:44-49.
10. Henriksen MG, Raballo A, Nordgaard J. Self-disorders and psychopathology: a systematic review. Lancet Psychiatry 2021;8:1001-1012.
11. Koren D, Tzivoni Y, Schalit L, Adres M, Reznik N, Apter A, et al. Basic self-disorders in adolescence predict schizophrenia spectrum disorders in young adulthood: a 7-year follow-up study among non-psychotic help-seeking adolescents. Schizophr Res 2020;216:97-103.
12. Süllwold L. [Die selbstwahrnehmung defizitärer störungen: psychologische aspekte des basisstörungskonzeptes]. In: Süllwold L, Huber G, editors. [Schizophrene basisstörungen]. Berlin, Heidelberg: Springer, 1986, p.1-38. German.
16. Flückiger R, Michel C, Grant P, Ruhrmann S, Vogeley K, Hubl D, et al. The interrelationship between schizotypy, clinical high risk for psychosis and related symptoms: cognitive disturbances matter. Schizophr Res 2019;210:188-196.
17. Chapman LJ, Chapman JP. Revised physical anhedonia scale. Madison: University of Wisconsin; 1978. Unpublished test.
18. Chapman LJ, Chapman JP, Raulin ML. Body-image aberration in schizophrenia. J Abnorm Psychol 1978;87:399-407.
19. Eckblad ML, Chapman LJ, Chapman JP, Mishlove M. The revised social anhedonia scale. Madison: University of Wisconsin; 1982. Unpublished test.
20. Eckblad M, Chapman LJ. Magical ideation as an indicator of schizotypy. J Consult Clin Psychol 1983;51:215-225.
22. Kwapil TR, Gross GM, Silvia PJ, Barrantes-Vidal N. Prediction of psychopathology and functional impairment by positive and negative schizotypy in the Chapmans’ ten-year longitudinal study. J Abnorm Psychol 2013;122:807-815.
24. Debbané M, Eliez S, Badoud D, Conus P, Flückiger R, Schultze-Lutter F. Developing psychosis and its risk states through the lens of schizotypy. Schizophr Bull 2015;41(Suppl 2):S396-S407.
25. Flückiger R, Ruhrmann S, Debbané M, Michel C, Hubl D, Schimmelmann BG, et al. Psychosis-predictive value of self-reported schizotypy in a clinical high-risk sample. J Abnorm Psychol 2016;125:923-932.
26. Corcoran R, Devan K, Durrant S, Liddle P. The relationship between schizotypal ideation and subjective cognition reflects more than just cognitive disorganisation: introducing the brief cognitive schizotypy index. Cogn Neuropsychiatry 2013;18:491-514.
27. Yon V, Loas G, Monestès JL. Relationships between schizotypy and subjective experiences in a sample of 399 university students. Compr Psychiatry 2009;50:142-150.
28. An SK, Kang JI, Park JY, Kim KR, Lee SY, Lee E. Attribution bias in ultrahigh risk for psychosis and first-episode schizophrenia. Schizophr Res 2010;118:54-61.
29. Kang JI, Park HJ, Kim SJ, Kim KR, Lee SY, Lee E, et al. Reduced binding potential of GABA-A/benzodiazepine receptors in individuals at ultra-high risk for psychosis: an [18F]-fluoroflumazenil positron emission tomography study. Schizophr Bull 2014;40:548-557.
30. First MB, Spitzer RL, Gibbon M, Williams JBW. Structured clinical interview for DSM-IV-TR axis I disorders, research version, patient edition (SCID-I/P). New York: Biometrics Research, New York State Psychiatric Institute; 2002.
31. First MB, Spitzer RL, Gibbon M, Williams JBW. Structured clinical interview for DSM-IV-TR axis I disorders, research version, non-patient edition (SCID-I/NP). New York: Biometrics Research, New York State Psychiatric Institute; 2002.
32. Miller TJ, McGlashan TH, Rosen JL, Cadenhead K, Cannon T, Ventura J, et al. Prodromal assessment with the structured interview for prodromal syndromes and the scale of prodromal symptoms: predictive validity, interrater reliability, and training to reliability. Schizophr Bull 2003;29:703-715.
33. Kay SR, Fiszbein A, Opler LA. The positive and negative syndrome scale (PANSS) for schizophrenia. Schizophr Bull 1987;13:261-276.
34. Gross G, Huber G, Klosterkötter J, Linz M. Bonn scale for the assessment of basic symptoms-BSABS. Berlin: Springer; 1987.
36. Raballo A, Monducci E, Ferrara M, Fiori Nastro P, Dario C, RODIN Group. Developmental vulnerability to psychosis: selective aggregation of basic self-disturbance in early onset schizophrenia. Schizophr Res 2018;201:367-372.
37. Nelson B, Lavoie S, Gawęda Ł, Li E, Sass LA, Koren D, et al. The neurophenomenology of early psychosis: an integrative empirical study. Conscious Cogn 2020;77:102845
38. Bleuler E. Dementia praecox or the group of schizophrenias. Zinkin J, translator. New York: International Universities Press; 1950.
40. Maß R. Eppendorf schizophrenia inventory (ESI) vs. Frankfurt complaint questionnaire (FCQ). Direct comparison in a clinical trial. Der Nervenarzt 2005;76:1109-1116.
41. Michel C, Kutschal C, Schimmelmann BG, Schultze-Lutter F. Convergent and concurrent validity of the Frankfurt complaint questionnaire as a screener for psychosis risk. J Risk Res 2017;20:1480-1496.
42. Mass R. Characteristic subjective experiences of schizophrenia. Schizophr Bull 2000;26:921-931.
43. Schultze-Lutter F, Wieneke A, Picker H, Rolff Y, Steinmeyer EM, Ruhrmann S, et al. The schizophrenia prediction instrument, adult version (SPI-A). Schizophr Res 2004;70:76-77.